Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Macrophage migration inhibitory factor -173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran.

Hashemi M, Sharifi-Mood B, Rasouli A, Amininia S, Naderi M, Taheri M.

EXCLI J. 2015 Jan 21;14:117-22. doi: 10.17179/excli2014-636. eCollection 2015.

2.

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus.

Lang T, Foote A, Lee JP, Morand EF, Harris J.

Front Immunol. 2015 Nov 11;6:577. doi: 10.3389/fimmu.2015.00577. eCollection 2015. Review.

3.

Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease.

Ji K, Wang X, Li J, Lu Q, Wang G, Xue Y, Zhang S, Qian L, Wu W, Zhu Y, Wang L, Liao L, Tang J.

Biomed Res Int. 2015;2015:315174. doi: 10.1155/2015/315174. Epub 2015 Mar 4.

4.

Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Wigren M, Nilsson J, Kaplan MJ.

J Intern Med. 2015 Nov;278(5):494-506. doi: 10.1111/joim.12357. Review.

PMID:
25720452
5.

Influence of molecular genetics in Vogt-Koyanagi-Harada disease.

Ng JY, Luk FO, Lai TY, Pang CP.

J Ophthalmic Inflamm Infect. 2014 Jul 22;4:20. doi: 10.1186/s12348-014-0020-1. eCollection 2014. Review.

6.

Dual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset Graves disease in a Taiwanese Chinese population.

Liu YH, Chen CC, Yang CM, Chen YJ, Tsai FJ.

PLoS One. 2014 Mar 25;9(3):e92849. doi: 10.1371/journal.pone.0092849. eCollection 2014.

7.

Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus.

De la Cruz-Mosso U, Bucala R, Palafox-Sánchez CA, Parra-Rojas I, Padilla-Gutiérrez JR, Pereira-Suárez AL, Rangel-Villalobos H, Vázquez-Villamar M, Angel-Chávez LI, Muñoz-Valle JF.

Hum Immunol. 2014 May;75(5):433-9. doi: 10.1016/j.humimm.2014.02.014. Epub 2014 Feb 12.

8.

A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.

Wang FF, Huang XF, Shen N, Leng L, Bucala R, Chen SL, Lu LJ.

Arthritis Res Ther. 2013;15(3):R65.

9.

Virtual screening and optimization yield low-nanomolar inhibitors of the tautomerase activity of Plasmodium falciparum macrophage migration inhibitory factor.

Dahlgren MK, Garcia AB, Hare AA, Tirado-Rives J, Leng L, Bucala R, Jorgensen WL.

J Med Chem. 2012 Nov 26;55(22):10148-59. doi: 10.1021/jm301269s. Epub 2012 Oct 26.

10.

A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF).

Bai F, Asojo OA, Cirillo P, Ciustea M, Ledizet M, Aristoff PA, Leng L, Koski RA, Powell TJ, Bucala R, Anthony KG.

J Biol Chem. 2012 Aug 31;287(36):30653-63. doi: 10.1074/jbc.M112.385583. Epub 2012 Jul 10.

11.

Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.

Sreih A, Ezzeddine R, Leng L, LaChance A, Yu G, Mizue Y, Subrahmanyan L, Pons-Estel BA, Abelson AK, Gunnarsson I, Svenungsson E, Cavett J, Glenn S, Zhang L, Montgomery R, Perl A, Salmon J, Alarcón-Riquelme ME, Harley JB, Bucala R.

Arthritis Rheum. 2011 Dec;63(12):3942-51. doi: 10.1002/art.30624.

12.

Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.

Kasama T, Ohtsuka K, Sato M, Takahashi R, Wakabayashi K, Kobayashi K.

Arthritis. 2010;2010:106202. doi: 10.1155/2010/106202. Epub 2010 Dec 26.

13.

A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.

Leng L, Chen L, Fan J, Greven D, Arjona A, Du X, Austin D, Kashgarian M, Yin Z, Huang XR, Lan HY, Lolis E, Nikolic-Paterson D, Bucala R.

J Immunol. 2011 Jan 1;186(1):527-38. doi: 10.4049/jimmunol.1001767. Epub 2010 Nov 24.

14.

Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.

Swanberg M, McGuigan F, Ivaska KK, Gerdhem P, Lerner UH, Bucala R, Kuchel G, Kenny A, Akesson K.

Bone. 2010 Aug;47(2):424-9. doi: 10.1016/j.bone.2010.05.009. Epub 2010 May 12.

15.

Recent advances in the genetics of systemic lupus erythematosus.

Flesher DL, Sun X, Behrens TW, Graham RR, Criswell LA.

Expert Rev Clin Immunol. 2010 May;6(3):461-79. doi: 10.1586/eci.10.8. Review.

16.

A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study.

Lehmann LE, Book M, Hartmann W, Weber SU, Schewe JC, Klaschik S, Hoeft A, Stüber F.

J Transl Med. 2009 Nov 26;7:100. doi: 10.1186/1479-5876-7-100.

17.

Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.

Cournia Z, Leng L, Gandavadi S, Du X, Bucala R, Jorgensen WL.

J Med Chem. 2009 Jan 22;52(2):416-24. doi: 10.1021/jm801100v.

18.

Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Winner M, Leng L, Zundel W, Mitchell RA.

Methods Enzymol. 2007;435:355-69. Review.

19.

Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease.

Oliver J, Márquez A, Gómez-Garcia M, Martinez A, Mendoza JL, Vilchez JR, López-Nevot MA, Piñero A, de la Concha EG, Nieto A, Urcelay E, Martín J.

Gut. 2007 Jan;56(1):150-1. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk